Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Diabetic Peripheral Neuropathy
Interventions
PROCEDURE

Skin biopsy

Skin biopsy specimens will processed and analyzed for Nerve fiber count, nerve and skin morphology, and sodium channel specific epitope expression in keratinocytes.

DRUG

Lidocaine 5% patches

Subject will apply patches to affected area QD for 12 hours then remove.

Trial Locations (1)

12208

Albany Medical College, Albany

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Endo Pharmaceuticals

INDUSTRY

lead

Albany Medical College

OTHER